Pharmacokinetics (PK) of Rilzabrutinib (PRN1008) in Healthy Japanese and Caucasian Subjects

Trial Identifier: PKM17089
Sponsor: Principia Biopharma, a Sanofi Company
Start Date: January 2021
Primary Completion Date: April 2021
Study Completion Date: April 2021
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
USA, California Glendale, California, USA, 91206